Results 51 to 60 of about 43,273 (272)

Microbial keratitis-induced endophthalmitis: incidence, symptoms, therapy, visual prognosis and outcomes [PDF]

open access: yes, 2018
Background: To evaluate symptoms, therapies and outcomes in rare microbial keratitis-induced endophthalmitis. Methods: Retrospective study with 11 patients treated between 2009 and 2014.
Feucht, Nikolaus   +6 more
core   +1 more source

Incidence of postoperative retinal detachment and bacterial endophthalmitis in the Swedish national paediatric cataract register and associated risk factors

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the incidence and risk factors of retinal detachment (RD) and bacterial endophthalmitis in a cohort of children who underwent cataract surgery before the age of eight. Methods Data was retrieved from the Swedish national paediatric cataract register.
Arzu Seyhan Karatepe Hashas   +8 more
wiley   +1 more source

Sucessfull management of bilateral presumed Candida endogenous endophtalmitis following pancreatitis

open access: yesRevista Brasileira de Oftalmologia, 2016
Endogenous endophthalmitis is a rare, and frequently devastating, ophthalmic disease. It occurs mostly in immunocompromised patients, or those with diabetes mellitus, cancer or intravenous drugs users.
Ricardo Evangelista Marrocos de Aragão   +5 more
doaj   +1 more source

Long‐term results after sutureless intrascleral fixation of the Carlevale intraocular lens: Changes in scleral pocket thickness over time

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the long‐term effects and dynamic changes in scleral thickness above the T‐haptic after sutureless scleral‐fixated intraocular lens (sSFIOL) implantation using the FIL‐SFF Carlevale lens. Setting Single‐centre, single‐surgeon, prospective clinical trial, Department of Ophthalmology, Medical University of Vienna, Austria.
Markus Schranz   +5 more
wiley   +1 more source

Ocular sequelae from the illicit use of class A drugs [PDF]

open access: yes, 2004
Aim: To highlight the changes that may take place in the visual system of the class A drug abuser. Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs.
Firth, A.Y.
core  

Delayed-onset endophthalmitis associated with corneal suture infections [PDF]

open access: yes, 2013
BACKGROUND: The purpose of the current study was to report the microbiology, risk factors, and treatment outcomes in patients with delayed-onset endophthalmitis associated with corneal suture infections.
Amy C Schefler   +5 more
core   +1 more source

Second‐Generation (44‐Channel) Suprachoroidal Retinal Prosthesis: Surgical Stability and Safety During a 2‐Year Clinical Trial

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To assess the safety and stability profile of the suprachoroidal retinal prosthesis (ScRP) in participants with retinitis pigmentosa (RP) for 2 years from implantation. Methods Four participants, with advanced RP and bare‐light perception vision were enrolled in a prospective, single arm unmasked interventional clinical trial and ...
Penelope J. Allen   +14 more
wiley   +1 more source

Role of Inflammation in Endophthalmitis [PDF]

open access: yesMediators of Inflammation, 2012
Inflammation originating from infection of the vitreous cavity is called endophthalmitis. Attention has been focused on the epidemiologic, microbiologic reports, and treatment options; unfortunately, the role of the host immune reaction in the visual function damage is still not well understood.
Vallejo Garcia J. L.   +4 more
openaire   +5 more sources

Preferred practice patterns of endophthalmitis management and prevention: A survey among the members of Vitreoretinal Society of India – Study by the VRSI study group

open access: yesIndian Journal of Ophthalmology
Purpose: To assess the preferred practice patterns of endophthalmitis management and prophylaxis among the members of Vitreo Retina Society of India (VRSI).
Deepanshu Agrawal   +7 more
doaj   +1 more source

Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy